Hughes, T. P., Saglio, G., Kantarjian, H. M., Guilhot, F., Niederwieser, D., Rosti, G., . . . Hochhaus, A. (2014). Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib. Blood.
Styl ChicagoHughes, Timothy P., et al. "Early Molecular Response Predicts Outcomes in Patients With Chronic Myeloid Leukemia in Chronic Phase Treated With Frontline Nilotinib or Imatinib." Blood 2014.
Citace podle MLAHughes, Timothy P., et al. "Early Molecular Response Predicts Outcomes in Patients With Chronic Myeloid Leukemia in Chronic Phase Treated With Frontline Nilotinib or Imatinib." Blood 2014.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..